A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Schmid, Peter ; Sablin, Marie-Paule ; Bergh, Jonas ; Im, Seock-Ah ; Lu, Yen-Shen ; Martínez, Noelia ; Neven, Patrick ; Lee, Keun Seok ; Morales, Serafín ; Pérez-Fidalgo, J Alejandro ; Adamson, Douglas ; Gonçalves, Anthony ; Prat, Aleix ; Jerusalem, Guy ; Schlieker, Laura ; Espadero, Rosa-Maria ; Bogenrieder, Thomas ; Huang, Dennis Chin-Lun ; Crown, John ; Cortés, Javier

Breast cancer research : BCR, 2021-01, Vol.23 (1), p.8-8, Article 8 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível